Enbiosis is a precision nutraceutical formulation platform. We license AI-designed, microbiome-targeted formulations to global brands and manufacturers.
Dozens of AI-designed formulations targeting a wide array of disease and wellness conditions.
⚙️
Multi-Format Adaptability
Precision science licensed across 5 core health categories into virtually any product format — from supplements to functional dairy.
🌐
Massive Global Capacity
Thousands of commercialisation slots across major regional clusters, offering unparalleled market entry opportunities.
The Digital Twin Advantage
Beyond Standard Approaches
We use Digital Twin AI technology to model microbiome interactions at scale. We don’t guess — we simulate the biological impact of every ingredient before it ever reaches the consumer.
Our engine processes thousands of ingredient interactions to identify the optimal combination for specific disease targets, producing formulations grounded in peer-reviewed science.
Our Unique Formula
Human Gut Microbiota
+ Digital Twin Technology
× Artificial Intelligence
= Next-Generation Nutraceuticals
Conditions We Address
👁 Eye Health
Dry Eye, Diabetic Retinopathy…
⚖️ Metabolic
Diabetes, metabolic syndrome…
🧠 Neurological
Alzheimer’s, Parkinson’s…
🫁 Digestive
IBS, IBD, Crohn’s disease…
💪 Weight
Weight loss, GLP-1 induction…
💆 Mental Health
Anxiety, depression, stress…
🌿 Urological
Hypogonadism, chronic pelvic pain…
🌸 Sexual Health
Libido, hormonal vitality…
⏳ Longevity
Precision personalised nutrition
Recognition
UK's #1 Clinically Proven AI Technology
Enbiosis has been active in the field of microbiome science for many years, with research published in some of the world’s leading scientific journals.